Sildenafil

Sildenafil is a well-characterized phosphodiesterase type 5 (PDE5) inhibitor that potentiates nitric oxide-cGMP signaling, leading to enhanced vasodilation and improved erectile function. Originally developed for angina, its superior efficacy in treating erectile dysfunction redirected its research trajectory. Sildenafil demonstrates a rapid onset of action and a moderate half-life, making it suitable for acute interventions in vascular biology and sexual health research. Beyond its primary applications, sildenafil has been explored for its potential benefits in pulmonary hypertension and endothelial function modulation. Its favorable pharmacodynamic profile continues to make sildenafil a valuable tool in experimental pharmacology and vascular studies.
This product is intended solely for laboratory research use and is not approved for human or veterinary applications, diagnostic procedures, therapeutic uses, or consumption. All products are sold under the condition that they will be handled exclusively by qualified individuals familiar with their use and potential risks. Any application of this material in humans or animals for therapeutic or diagnostic purposes must comply with the regulations established in 21 CFR 312 and 21 CFR 600.